| Literature DB >> 26366183 |
Eungyeong Jang1, Bum-Joon Kim2, Kyung-Tae Lee3, Kyung-Soo Inn4, Jang-Hoon Lee1.
Abstract
Artemisia capillaris has been recognized as an herb with therapeutic efficacy in liver diseases and widely used as an alternative therapy in Asia. Numerous studies have reported the antisteatotic, antioxidant, anti-inflammatory, choleretic, antiviral, antifibrotic, and antitumor activities of A. capillaris. These reports support its therapeutic potential in various liver diseases such as chronic hepatitis B virus (HBV) infection, cirrhosis, and hepatocellular carcinoma. In addition, several properties of its various constituents, which provide clues to the underlying mechanisms of its therapeutic effects, have been studied. This review describes the scientific evidence supporting the therapeutic potential of A. capillaris and its constituents in various liver diseases.Entities:
Year: 2015 PMID: 26366183 PMCID: PMC4558445 DOI: 10.1155/2015/728137
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Schematic diagram of major effects of A. capillaris in order of progression of liver diseases. The lower box indicates reported therapeutic activities of A. capillaris related to liver pathological conditions in the upper box.
Experimental results based on key activities of Artemisia capillaris.
| Herb names (ingredients, country) | Extracts | Type | Doses | Model | Results | References |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Water |
| 200 mg/kg | CCl4-injected rats | Liver weight↓ | [ |
|
| Water |
| 0.05, 0.1 g/kg | High-fat diet induced obese mice | SOD↑ | [ |
|
| Water |
| Rats with bile duct ligation | MDA↓ | [ | |
|
| Water |
| 50, 100 mg/kg | Alcohol-pyrazole-fed rat | AST, ALT↓ | [ |
|
| ||||||
|
| ||||||
|
| Ethanol |
| 100 | FFAs-treated HepG2 | Lipid accumulation↓ | [ |
|
|
| 100 mg/kg | C57BL/6J mice fed a high-fat diet | Mitochondrial | [ | |
|
|
| High-fat diet induced obese rats | TG↓ | [ | ||
|
| ||||||
|
| ||||||
|
| Water |
| RINm5F rat insulinoma cells | NO↓ | [ | |
|
| Water |
| LPS-induced HepG2 and rat liver | iNOS↓ | [ | |
|
| Methanol |
| 10 | Rat splenocytes | iNOS↓ | [ |
|
| ||||||
|
| ||||||
|
| Ethanol |
| HepG2.2.15 | HBsAg↓ | [ | |
|
|
| HepG2.2.15 | HBV DNA↓ | [ | ||
|
| ||||||
|
| ||||||
|
| Water |
| 3 mL/day | Rats | Bile flow↑ | [ |
|
|
| 50 mg/kg | Rats | Bile secretion↑ | [ | |
|
| ||||||
|
| ||||||
|
| Water |
| 50 mg/kg | Rats with bile duct ligation |
| [ |
|
|
| 120 | LX2 cells | Collagen-1↓ | [ | |
|
|
| 40 mg/kg | DMN-induced fibrotic mouse | Collagen-1↓ | [ | |
|
| Water |
| CCl4-induced rats | PDGF- | [ | |
|
| ||||||
|
| ||||||
|
| Water |
| 2 | HL-60 cells | Cell growth↓ | [ |
|
| Water |
| 25~200 | SMMC-7721, human hepatoma cell line | Cell growth↓ | [ |
Various effects of constituents isolated and derived from Artemisia capillaris.
| Compounds | Plants | Effects | References |
|---|---|---|---|
| Scoparone |
| Vascular dilatory action | [ |
|
| Choleretic | [ | |
|
| Antihypertensive | [ | |
|
| Antioxidant | [ | |
|
| Anti-inflammatory | [ | |
|
| |||
| Capillartemisin |
| Choleretic | [ |
|
| |||
| Capillarisin |
| Antitumor | [ |
|
| |||
| Capillin |
| Anti-inflammatory | [ |
|
| Antitumor | [ | |
|
| Antitumor | [ | |
|
| |||
| Scopoletin |
| Choleretic | [ |
|
| Antioxidant | [ | |
|
| Antioxidant | [ | |
|
| Antioxidant | [ | |
|
| Antisteatotic | [ | |
|
| Anti-inflammatory | [ | |
|
| Antitumor | [ | |
|
| Antitumor | [ | |
|
| |||
| Isoscopoletin |
| Choleretic | [ |
|
| |||
| Artepillin |
| Choleretic | [ |
|
| |||
|
|
| Choleretic | [ |
|
| |||
| Esculetin | Unknown | Choleretic | [ |
|
| |||
| Chlorogenic |
| Antioxidant | [ |
|
| Antioxidant | [ | |
|
| Antioxidant | [ | |
|
| |||
| Isochlorogenic acid |
| Antioxidant | [ |
|
| Antiviral and antioxidant | [ | |
|
| Anti-inflammatory |
[ | |
|
| Antitumor | [ | |
|
| |||
|
|
| Antifibrotic | [ |
|
| |||
| Quercetin | Chemical agents | Antitumor | [ |
|
| |||
| Umbelliferone | Chemical agents | Antisteatotic | [ |
|
| |||
| Pumilaside A |
| Antiviral | [ |
Figure 2Chemical structures of selected compounds with therapeutic effects on liver diseases.
Figure 3Constituents of A. capillaris effective to each progressive stage of liver disease.